Literature DB >> 5285383

Disposition kinetics of lidocaine in normal subjects.

M Rowland, P D Thomson, A Guichard, K L Melmon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5285383     DOI： 10.1111/j.1749-6632.1971.tb46915.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  38 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.

Authors:  D P Vaughan; G T Tucker
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

Review 3.  Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.

Authors:  Maria D Donovan; Geraldine B Boylan; Deirdre M Murray; John F Cryan; Brendan T Griffin
Journal:  Br J Clin Pharmacol       Date:  2015-11-04       Impact factor: 4.335

4.  Lignocaine: a new technique for intravenous administration.

Authors:  R A Levy; Y Charuzi; W J Mandel
Journal:  Br Heart J       Date:  1977-09

5.  The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans.

Authors:  C Reichel; T Skodra; A Nacke; U Spengler; T Sauerbruch
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

6.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

7.  Linear pharmacokinetics: calculation of the loading dose for two-compartment models with intermittent infusions.

Authors:  N P Chau
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

8.  The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects.

Authors:  A H Thomson; H L Elliott; A W Kelman; P A Meredith; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

9.  The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine.

Authors:  G W Mihaly; R G Moore; J Thomas; E J Triggs; D Thomas; C A Shanks
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.